Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies
Recruiting
Observational Study
Low-grade Glioma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Hospital Italiano de Buenos Aires · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Low-grade gliomas (LGG) are slow-growing primary brain tumors (WHO grades I-II), and their incidence, survival, and treatment patterns in middle-income settings such as Argentina remain poorly characterized. This retrospective, multicenter study comprises two complementary cohorts:
1. Cohort 1: The "captive" population covered under the Hospital Italiano de Buenos Aires Health Plan (January 2011-…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Study population cohort 1
* Inclusion Criteria
* Adult patients (≥18 years old) affiliated to the health plan of Hospital Italiano de Buenos Aires.
* Documented clinical follow-up of at least 1 year during the study period.
* Exclusion Criteria
* Patients not affiliated to the health plan o…
Contacts